Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
deals
fda
investing
4
×
life sciences
national blog main
san francisco blog main
boston top stories
national top stories
san francisco top stories
boston
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
drugs
eli lilly
genentech
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
abbvie
What
fda
4
×
drug
approved
bio
medicines
roundup
affects
ahead
americans
approval
asco
blueprint
branded
cancer
candidate
choices
commissioner
companies
consumers
costly
counterweight
currently
date
developing
digital
disease
drugs
elevatebio
epidemic
fatty
frenzied
frequency
generic
graft
growing
hearing
ipo
known
led
liver
Language
unset
Current search:
investing
×
fda
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
